Last 12 months
Inside the activity.
1 purchase rows · 79 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 0 | 17 |
| Jan 2026 | 0 | 8 |
| Feb 2026 | 0 | 3 |
| Mar 2026 | 0 | 18 |
| Apr 2026 | 0 | 8 |
| May 2026 | 0 | 3 |
| Jun 2026 | 1 | 7 |
| Jul 2026 | 0 | 4 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 5 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 15, 2024 Filed Nov 16, 2024 01:11 UTC |
Maroney Dawn ChristinePresident, Markets
|
SaleCommon Stock | 30,000 | $11.35 | $340,560.00 |
DisclosureSEC source: 0001628280-24-048161 · wk-form4_1731719470.xml · nonDerivative · entry 1 Maroney Dawn Christine · CIK 0001850397 · President, Markets 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,696,097 F1 · kind: Date of Rule 10b5-1 plan adoption: 03/13/2024 F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $10.97 to $11.56. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| November 11, 2024 Filed Nov 13, 2024 17:16 UTC |
Freeman Robert ThomasChief Financial Officer
|
SaleCommon Stock | 30,500 | $13.42 | $409,355.75 |
DisclosureSEC source: 0001628280-24-047671 · wk-form4_1731536168.xml · nonDerivative · entry 1 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 92,929 F1 · kind: Date of Rule 10b5-1 plan adoption: 03/15/2024 F2 · ownership.nature: Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary. Read SEC document |
| November 11, 2024 Filed Nov 13, 2024 22:14 UTC |
KAO JOHN EDirector · Chief Executive Officer
|
SaleCommon Stock | 90,000 | $13.42 | $1,207,944.00 |
DisclosureSEC source: 0001628280-24-047669 · wk-form4_1731536040.xml · nonDerivative · entry 1 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 2,453,100 F1 · kind: Date of Rule 10b5-1 plan adoption: 03/14/2024 F2 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. Read SEC document |
| November 11, 2024 Filed Nov 13, 2024 22:18 UTC |
KONOWIECKI JOSEPH SDirector
|
SaleCommon Stock | 6,920 | $13.73 | $95,011.60 |
DisclosureSEC source: 0001628280-24-047673 · wk-form4_1731536322.xml · nonDerivative · entry 1 KONOWIECKI JOSEPH S · CIK 0001209523 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,134,888 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person. Read SEC document |
| November 04, 2024 Filed Nov 5, 2024 23:06 UTC |
Kardes HakanChief Experience Officer
|
SaleCommon Stock | 20,500 | $13.06 | $267,699.25 |
DisclosureSEC source: 0001628280-24-045399 · wk-form4_1730847983.xml · nonDerivative · entry 2 Kardes Hakan · CIK 0001975023 · Chief Experience Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 355,444 F1 · kind: Date of Rule 10b5-1 plan adoption: 03/14/2024 F3 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $12.98 to $13.25. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| November 01, 2024 Filed Nov 5, 2024 23:06 UTC |
Kardes HakanChief Experience Officer
|
SaleCommon Stock | 4,500 | $12.98 | $58,413.15 |
DisclosureSEC source: 0001628280-24-045399 · wk-form4_1730847983.xml · nonDerivative · entry 1 Kardes Hakan · CIK 0001975023 · Chief Experience Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 375,944 F1 · kind: Date of Rule 10b5-1 plan adoption: 03/14/2024 F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $12.98 to $12.99. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| October 31, 2024 Filed Oct 31, 2024 18:11 UTC |
Freeman Robert ThomasChief Financial Officer
|
SaleCommon Stock | 36,197 | $12.04 | $435,982.01 |
DisclosureSEC source: 0001628280-24-044631 · wk-form4_1730412691.xml · nonDerivative · entry 2 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 123,429 F1 · kind: Date of Rule 10b5-1 plan adoption: 03/15/2024 F4 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $12.00 to $12.24. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F3 · ownership.nature: Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary. Read SEC document |
| October 29, 2024 Filed Oct 31, 2024 18:11 UTC |
Freeman Robert ThomasChief Financial Officer
|
SaleCommon Stock | 4,483 | $12.01 | $53,856.07 |
DisclosureSEC source: 0001628280-24-044631 · wk-form4_1730412691.xml · nonDerivative · entry 1 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 159,626 F1 · kind: Date of Rule 10b5-1 plan adoption: 03/15/2024 F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $12.00 to $12.05. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F3 · ownership.nature: Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary. Read SEC document |
| October 15, 2024 Filed Oct 16, 2024 21:40 UTC |
Maroney Dawn ChristinePresident, Markets
|
SaleCommon Stock | 30,000 | $10.77 | $323,082.00 |
DisclosureSEC source: 0001628280-24-042957 · wk-form4_1729114794.xml · nonDerivative · entry 1 Maroney Dawn Christine · CIK 0001850397 · President, Markets 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,726,097 F1 · kind: Date of Rule 10b5-1 plan adoption: 03/13/2024 F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $10.65 to $11.05. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| October 14, 2024 Filed Oct 16, 2024 17:37 UTC |
Freeman Robert ThomasChief Financial Officer
|
SaleCommon Stock | 30,500 | $11.50 | $350,872.00 |
DisclosureSEC source: 0001628280-24-042955 · wk-form4_1729114671.xml · nonDerivative · entry 1 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 164,109 F1 · kind: Date of Rule 10b5-1 plan adoption: 03/15/2024 F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $11.25 to $11.71. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F3 · ownership.nature: Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary. Read SEC document |
| October 09, 2024 Filed Oct 10, 2024 22:57 UTC |
KAO JOHN EDirector · Chief Executive Officer
|
SaleCommon Stock | 90,000 | $11.33 | $1,019,538.00 |
DisclosureSEC source: 0001628280-24-042686 · wk-form4_1728601055.xml · nonDerivative · entry 1 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 2,543,100 F1 · kind: Date of Rule 10b5-1 plan adoption: 03/14/2024 F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $11.01 to $11.92. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F3 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. Read SEC document |
| October 08, 2024 Filed Oct 10, 2024 18:56 UTC |
Freeman Robert ThomasChief Financial Officer
|
SaleCommon Stock | 39,320 | $12.04 | $473,349.89 |
DisclosureSEC source: 0001628280-24-042685 · wk-form4_1728600979.xml · nonDerivative · entry 1 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 194,609 F1 · kind: Date of Rule 10b5-1 plan adoption: 03/15/2024 F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $12.00 to $12.20. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F3 · ownership.nature: Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary. Read SEC document |
| October 08, 2024 Filed Oct 10, 2024 22:58 UTC |
Kim HyongChief Medical Officer
|
SaleCommon Stock | 22,460 | $11.03 | $247,733.80 |
DisclosureSEC source: 0001628280-24-042687 · wk-form4_1728601124.xml · nonDerivative · entry 1 Kim Hyong · CIK 0001993255 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 533,070 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person. Read SEC document |
| October 02, 2024 Filed Oct 3, 2024 18:17 UTC |
Freeman Robert ThomasChief Financial Officer
|
SaleCommon Stock | 9,125 | $11.01 | $100,432.49 |
DisclosureSEC source: 0001628280-24-042224 · wk-form4_1727993843.xml · nonDerivative · entry 3 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 233,929 F4 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $11.00 to $11.04. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F2 · ownership.nature: Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 18:19 UTC |
JOYCE CHRISTOPHER JChief Legal and Admin. Officer
|
SaleCommon Stock | 667 | $11.79 | $7,865.73 |
DisclosureSEC source: 0001628280-24-042225 · wk-form4_1727993952.xml · nonDerivative · entry 1 JOYCE CHRISTOPHER J · CIK 0001032563 · Chief Legal and Admin. Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 364,445 F1 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $11.77 to $11.845. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 18:17 UTC |
Freeman Robert ThomasChief Financial Officer
|
SaleCommon Stock | 9,175 | $11.38 | $104,424.35 |
DisclosureSEC source: 0001628280-24-042224 · wk-form4_1727993843.xml · nonDerivative · entry 2 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 243,054 F3 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $11.00 to $11.86. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F2 · ownership.nature: Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 18:17 UTC |
Freeman Robert ThomasChief Financial Officer
|
SaleCommon Stock | 12,200 | $10.11 | $123,399.34 |
DisclosureSEC source: 0001628280-24-042224 · wk-form4_1727993843.xml · nonDerivative · entry 1 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 252,229 F1 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $10.00 to $10.99. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F2 · ownership.nature: Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary. Read SEC document |
| September 17, 2024 Filed Sep 18, 2024 20:18 UTC |
KONOWIECKI JOSEPH SDirector
|
SaleCommon Stock | 16,413 | $11.77 | $193,181.01 |
DisclosureSEC source: 0001628280-24-040795 · wk-form4_1726690706.xml · nonDerivative · entry 1 KONOWIECKI JOSEPH S · CIK 0001209523 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,141,808 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person. Read SEC document |
| September 16, 2024 Filed Sep 18, 2024 20:20 UTC |
Maroney Dawn ChristinePresident, Markets
|
SaleCommon Stock | 30,000 | $11.70 | $351,027.00 |
DisclosureSEC source: 0001628280-24-040799 · wk-form4_1726690838.xml · nonDerivative · entry 1 Maroney Dawn Christine · CIK 0001850397 · President, Markets 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,756,097 F1 · kind: Date of Rule 10b5-1 plan adoption: 03/13/2024 F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $11.44 to $12.07. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| September 16, 2024 Filed Sep 18, 2024 20:16 UTC |
KAO JOHN EDirector · Chief Executive Officer
|
SaleCommon Stock | 90,000 | $11.70 | $1,052,874.00 |
DisclosureSEC source: 0001628280-24-040790 · wk-form4_1726690586.xml · nonDerivative · entry 1 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 2,633,100 F1 · kind: Date of Rule 10b5-1 plan adoption: 03/14/2024 F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $11.43 to $12.06. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F3 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. Read SEC document |
| September 13, 2024 Filed Sep 13, 2024 18:19 UTC |
Freeman Robert ThomasChief Financial Officer
|
SaleCommon Stock | 14,500 | $12.00 | $174,013.05 |
DisclosureSEC source: 0001628280-24-040383 · wk-form4_1726265980.xml · nonDerivative · entry 3 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 264,429 F1 · kind: Date of adoption of Rule 10b5-1 plan: 03/15/2024 F5 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $12.00 to $12.01. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F3 · ownership.nature: Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary. Read SEC document |
| September 13, 2024 Filed Sep 13, 2024 22:21 UTC |
KONOWIECKI JOSEPH SDirector
|
SaleCommon Stock | 25,000 | $12.00 | $300,012.50 |
DisclosureSEC source: 0001628280-24-040385 · wk-form4_1726266109.xml · nonDerivative · entry 2 KONOWIECKI JOSEPH S · CIK 0001209523 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,158,221 F1 · kind: Date of adoption of Rule 10b5-1 plan: 03/07/2024 F3 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $12.00 to $12.01. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| September 12, 2024 Filed Sep 13, 2024 18:19 UTC |
Freeman Robert ThomasChief Financial Officer
|
SaleCommon Stock | 120,500 | $11.00 | $1,326,054.30 |
DisclosureSEC source: 0001628280-24-040383 · wk-form4_1726265980.xml · nonDerivative · entry 2 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 278,929 F1 · kind: Date of adoption of Rule 10b5-1 plan: 03/15/2024 F4 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $11.00 to $11.06. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F3 · ownership.nature: Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary. Read SEC document |
| September 12, 2024 Filed Sep 13, 2024 22:21 UTC |
KONOWIECKI JOSEPH SDirector
|
SaleCommon Stock | 25,000 | $11.00 | $275,092.50 |
DisclosureSEC source: 0001628280-24-040385 · wk-form4_1726266109.xml · nonDerivative · entry 1 KONOWIECKI JOSEPH S · CIK 0001209523 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,183,221 F1 · kind: Date of adoption of Rule 10b5-1 plan: 03/07/2024 F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $11.00 to $11.0685. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| September 12, 2024 Filed Sep 13, 2024 22:24 UTC |
Kardes HakanChief Experience Officer
|
SaleCommon Stock | 25,000 | $11.48 | $287,052.50 |
DisclosureSEC source: 0001628280-24-040387 · wk-form4_1726266240.xml · nonDerivative · entry 1 Kardes Hakan · CIK 0001975023 · Chief Experience Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 380,444 F1 · kind: Date of adoption of Rule 10b5-1 plan: 03/14/2024 F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $11.48 to $11.49. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| September 11, 2024 Filed Sep 13, 2024 18:22 UTC |
JOYCE CHRISTOPHER JChief Legal and Admin. Officer
|
SaleCommon Stock | 10,159 | $10.01 | $101,711.91 |
DisclosureSEC source: 0001628280-24-040386 · wk-form4_1726266164.xml · nonDerivative · entry 2 JOYCE CHRISTOPHER J · CIK 0001032563 · Chief Legal and Admin. Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 365,112 F2 · kind: Date of adoption of Rule 10b5-1 plan: 3/15/2024 F3 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $10.00 to $10.07. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| September 11, 2024 Filed Sep 13, 2024 18:22 UTC |
JOYCE CHRISTOPHER JChief Legal and Admin. Officer
|
SaleCommon Stock | 24,467 | $9.45 | $231,213.15 |
DisclosureSEC source: 0001628280-24-040386 · wk-form4_1726266164.xml · nonDerivative · entry 1 JOYCE CHRISTOPHER J · CIK 0001032563 · Chief Legal and Admin. Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 375,271 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person. Read SEC document |
| September 11, 2024 Filed Sep 13, 2024 18:19 UTC |
Freeman Robert ThomasChief Financial Officer
|
SaleCommon Stock | 8,561 | $10.01 | $85,687.91 |
DisclosureSEC source: 0001628280-24-040383 · wk-form4_1726265980.xml · nonDerivative · entry 1 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 399,429 F1 · kind: Date of adoption of Rule 10b5-1 plan: 03/15/2024 F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $10.00 to $10.04. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F3 · ownership.nature: Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary. Read SEC document |
| September 05, 2024 Filed Sep 6, 2024 17:29 UTC |
JOYCE CHRISTOPHER JChief Legal and Admin. Officer
|
SaleCommon Stock | 4,541 | $10.00 | $45,421.81 |
DisclosureSEC source: 0001628280-24-039740 · wk-form4_1725658168.xml · nonDerivative · entry 2 JOYCE CHRISTOPHER J · CIK 0001032563 · Chief Legal and Admin. Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 399,738 F1 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $10.00 to $10.06. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| September 05, 2024 Filed Sep 6, 2024 17:28 UTC |
Freeman Robert ThomasChief Financial Officer
|
SaleCommon Stock | 4,789 | $10.00 | $47,912.99 |
DisclosureSEC source: 0001628280-24-039739 · wk-form4_1725658113.xml · nonDerivative · entry 3 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 407,990 F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $10.00 to $10.08. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F1 · ownership.nature: Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary. Read SEC document |
| September 04, 2024 Filed Sep 6, 2024 17:29 UTC |
JOYCE CHRISTOPHER JChief Legal and Admin. Officer
|
SaleCommon Stock | 1,300 | $10.00 | $13,000.00 |
DisclosureSEC source: 0001628280-24-039740 · wk-form4_1725658168.xml · nonDerivative · entry 1 JOYCE CHRISTOPHER J · CIK 0001032563 · Chief Legal and Admin. Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 404,279 Read SEC document |
| September 04, 2024 Filed Sep 6, 2024 17:28 UTC |
Freeman Robert ThomasChief Financial Officer
|
SaleCommon Stock | 10 | $10.01 | $100.10 |
DisclosureSEC source: 0001628280-24-039739 · wk-form4_1725658113.xml · nonDerivative · entry 2 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 412,779 F1 · ownership.nature: Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary. Read SEC document |
| September 04, 2024 Filed Sep 6, 2024 17:28 UTC |
Freeman Robert ThomasChief Financial Officer
|
SaleCommon Stock | 1,640 | $10.00 | $16,400.00 |
DisclosureSEC source: 0001628280-24-039739 · wk-form4_1725658113.xml · nonDerivative · entry 1 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 412,789 F1 · ownership.nature: Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary. Read SEC document |
| August 23, 2024 Filed Aug 23, 2024 21:27 UTC |
Maroney Dawn ChristinePresident, Markets
|
SaleCommon Stock | 2,926 | $9.06 | $26,509.56 |
DisclosureSEC source: 0001628280-24-038373 · wk-form4_1724448452.xml · nonDerivative · entry 2 Maroney Dawn Christine · CIK 0001850397 · President, Markets 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,786,097 F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $9.04 to $9.10. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| August 22, 2024 Filed Aug 23, 2024 21:27 UTC |
Maroney Dawn ChristinePresident, Markets
|
SaleCommon Stock | 7,074 | $9.02 | $63,779.89 |
DisclosureSEC source: 0001628280-24-038373 · wk-form4_1724448452.xml · nonDerivative · entry 1 Maroney Dawn Christine · CIK 0001850397 · President, Markets 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,789,023 F1 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $9.00 to $9.04. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| August 15, 2024 Filed Aug 16, 2024 20:51 UTC |
Maroney Dawn ChristinePresident, Markets
|
SaleCommon Stock | 20,000 | $8.70 | $174,020.00 |
DisclosureSEC source: 0001628280-24-037583 · wk-form4_1723841506.xml · nonDerivative · entry 1 Maroney Dawn Christine · CIK 0001850397 · President, Markets 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,796,097 F1 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $8.59 to $8.81. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| August 14, 2024 Filed Aug 16, 2024 16:47 UTC |
MARGOLIS JEFFREY HDirector
|
SaleCommon Stock | 1,200 | $8.83 | $10,596.00 |
DisclosureSEC source: 0001628280-24-037579 · wk-form4_1723841269.xml · nonDerivative · entry 1 MARGOLIS JEFFREY H · CIK 0001105688 · Director 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 413,533 F1 · ownership.nature: Represents securities held by the Margolis Family trust 12/23/98, of which Mr. Margolis is the trustee. Read SEC document |
| August 02, 2024 Filed Aug 6, 2024 18:13 UTC |
JOYCE CHRISTOPHER JChief Legal and Admin. Officer
|
SaleCommon Stock | 100 | $9.01 | $901.00 |
DisclosureSEC source: 0001628280-24-035296 · wk-form4_1722982394.xml · nonDerivative · entry 2 JOYCE CHRISTOPHER J · CIK 0001032563 · Chief Legal and Admin. Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 405,579 Read SEC document |
| August 02, 2024 Filed Aug 6, 2024 18:13 UTC |
JOYCE CHRISTOPHER JChief Legal and Admin. Officer
|
SaleCommon Stock | 1,233 | $9.00 | $11,097.00 |
DisclosureSEC source: 0001628280-24-035296 · wk-form4_1722982394.xml · nonDerivative · entry 1 JOYCE CHRISTOPHER J · CIK 0001032563 · Chief Legal and Admin. Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 405,679 Read SEC document |
| July 19, 2024 Filed Jul 20, 2024 00:24 UTC |
Maroney Dawn ChristinePresident, Markets
|
SaleCommon Stock | 36,700 | $10.01 | $367,209.19 |
DisclosureSEC source: 0001628280-24-032363 · wk-form4_1721435084.xml · nonDerivative · entry 4 Maroney Dawn Christine · CIK 0001850397 · President, Markets 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,816,097 F1 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $10.00 to $10.06. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| July 19, 2024 Filed Jul 19, 2024 20:22 UTC |
Freeman Robert ThomasChief Financial Officer
|
SaleCommon Stock | 38,858 | $10.01 | $388,789.83 |
DisclosureSEC source: 0001628280-24-032361 · wk-form4_1721434921.xml · nonDerivative · entry 3 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 414,429 F1 · ownership.nature: Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary. Read SEC document |
| July 18, 2024 Filed Jul 20, 2024 00:24 UTC |
Maroney Dawn ChristinePresident, Markets
|
SaleCommon Stock | 832 | $10.01 | $8,328.32 |
DisclosureSEC source: 0001628280-24-032363 · wk-form4_1721435084.xml · nonDerivative · entry 3 Maroney Dawn Christine · CIK 0001850397 · President, Markets 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,852,797 Read SEC document |
| July 18, 2024 Filed Jul 20, 2024 00:24 UTC |
Maroney Dawn ChristinePresident, Markets
|
SaleCommon Stock | 39,305 | $10.00 | $393,050.00 |
DisclosureSEC source: 0001628280-24-032363 · wk-form4_1721435084.xml · nonDerivative · entry 2 Maroney Dawn Christine · CIK 0001850397 · President, Markets 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,853,629 Read SEC document |
| July 18, 2024 Filed Jul 19, 2024 20:22 UTC |
Freeman Robert ThomasChief Financial Officer
|
SaleCommon Stock | 44,042 | $10.00 | $440,433.21 |
DisclosureSEC source: 0001628280-24-032361 · wk-form4_1721434921.xml · nonDerivative · entry 2 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 453,287 F1 · ownership.nature: Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary. Read SEC document |
| July 17, 2024 Filed Jul 20, 2024 00:24 UTC |
Maroney Dawn ChristinePresident, Markets
|
SaleCommon Stock | 23,163 | $10.00 | $231,641.58 |
DisclosureSEC source: 0001628280-24-032363 · wk-form4_1721435084.xml · nonDerivative · entry 1 Maroney Dawn Christine · CIK 0001850397 · President, Markets 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,892,934 Read SEC document |
| July 17, 2024 Filed Jul 19, 2024 20:22 UTC |
Freeman Robert ThomasChief Financial Officer
|
SaleCommon Stock | 22,100 | $10.00 | $221,013.26 |
DisclosureSEC source: 0001628280-24-032361 · wk-form4_1721434921.xml · nonDerivative · entry 1 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 497,329 F1 · ownership.nature: Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary. Read SEC document |
| July 17, 2024 Filed Jul 20, 2024 00:27 UTC |
KONOWIECKI JOSEPH SDirector
|
SaleCommon Stock | 100 | $10.01 | $1,001.00 |
DisclosureSEC source: 0001628280-24-032365 · wk-form4_1721435216.xml · nonDerivative · entry 2 KONOWIECKI JOSEPH S · CIK 0001209523 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,208,221 Read SEC document |
| July 17, 2024 Filed Jul 20, 2024 00:27 UTC |
KONOWIECKI JOSEPH SDirector
|
SaleCommon Stock | 24,900 | $10.00 | $249,000.00 |
DisclosureSEC source: 0001628280-24-032365 · wk-form4_1721435216.xml · nonDerivative · entry 1 KONOWIECKI JOSEPH S · CIK 0001209523 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,208,321 Read SEC document |
| July 16, 2024 Filed Jul 18, 2024 20:41 UTC |
Kardes HakanChief Experience Officer
|
SaleCommon Stock | 25,000 | $9.98 | $249,500.00 |
DisclosureSEC source: 0001628280-24-032236 · wk-form4_1721335302.xml · nonDerivative · entry 1 Kardes Hakan · CIK 0001975023 · Chief Experience Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 405,444 Read SEC document |
| July 15, 2024 Filed Jul 16, 2024 16:33 UTC |
MARGOLIS JEFFREY HDirector
|
SaleCommon Stock | 1,200 | $8.94 | $10,728.00 |
DisclosureSEC source: 0001628280-24-031967 · wk-form4_1721162010.xml · nonDerivative · entry 1 MARGOLIS JEFFREY H · CIK 0001105688 · Director 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 414,733 F1 · ownership.nature: Represents securities held by the Margolis Family trust 12/23/98, of which Mr. Margolis is the trustee. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.